N-acylglucosamine 2-epimerase

BE0000109ProteinHumansRENBP

Catalyzes the interconversion of N-acetylglucosamine to N-acetylmannosamine (PubMed:10502668, PubMed:12499362, PubMed:9990133). It is acted on by 2 drugs in DrugBank.

Gene name
RENBP
UniProtKB entry
P51606Swiss-Prot
Residues / weight
427 residues · 48,831 Da
Also known as
5.1.3.8 · AGE · GlcNAc 2-epimerase · N-acetyl-D-glucosamine 2-epimerase · Renin-binding protein

Resolves to

Protein
UniProtP51606UniProt nameRENBP_HUMAN
Gene
HGNCHGNC:9959NCBI Gene5973GenBank220053GeneCardsRENBP
Pharmacology
KEGGhsa:5973
Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
4GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on N-acylglucosamine 2-epimerase, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In